The legacy of Viagra, and its developer copyright, presents a challenging case study for investors. At first a blockbuster drug, generating billions in revenue , its intellectual property lapse created a deluge https://mysitesname.com/story11339637/sildenafil-and-the-pharmaceutical-sector-a-uncertain-investment